Skip to main content
Top

Current Breast Cancer Reports

Issue 1/2024

Content (13 Articles)

Upgrade Rate and Long-term Outcomes of Lobular Neoplasia

Sara Ardila, Annabel Chen, Taylor Maramara, Danielle Henry, April Phantana-angkool

Clinical Relevance of Radial Scars: A Review of the Current Literature

Andrew Seto, Pabel Miah, Preeti Kodavanti Farmah, Kathryn Duckworth, Yassmen Hammam, Swapna Ghanta

Minimizing Breast Cancer Risk with Diet and Exercise

Taylor Maramara, Monique Couto Matos, Sara Ardila, April Phantana-angkool, Danielle Henry

Disparities in DCIS

Georgia Syrnioti, Josh Johnson, Claire M. Eden, Antonia Syrnioti, Lisa A. Newman

Patients Drive Authentic Trusted Solutions for Inclusive Clinical Trials

Maimah Karmo, Katherine Cornish, Virginia Leach, Jeanne Regnante

Breast Cancer in the Ashkenazi Jewish Population

Melissa K. Frey, Luiza R. Perez, Jesse T. Brewer, Adina K. Fleischmann, Elana Silber

Disparities in Hormone Receptor-Positive Breast Cancer

Esther R. Ogayo, Elizabeth A. Mittendorf, Olga Kantor

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine